| Study quality indicators | NCCN guidelines | AHNS quality indicators | Scottish Task Force v1 – quality indicators |
|---|---|---|---|
| Diagnosis and staging indicators | |||
| Pathological diagnosis (biopsy)† | + | + | + |
| Staging documentation† | + | + | + |
| MDT† | + | + | + |
| Appropriate imaging† | + | +‡ | +‡ |
| Smoking cessation support/counselling† | + | + | + |
| Dental assessment† | + | + | |
| Nutritional assessment† | + | + | |
| Speech pathology assessment† | + | + | |
| Treatment indicators | + | ||
| Appropriate RT§ | + | ||
| Appropriate IMRT† | + | ||
| Appropriate surgery§ | + | ||
| Appropriate chemotherapy§ | + | ||
| Surgical margins† | + | ||
| Time to PORT < 6 weeks† | + | + | |
| Appropriate CRT† | +¶ | +¶ | + |
| 30‐day mortality† | + | ||
| Post‐treatment indicators | + | ||
| Follow up – 1st year† | + | +†† | + |
| Follow up – 2nd year† | + | +†† | + |
| Follow up – years 3 – 5† | + | +†† | + |
| Imaging† | +‡‡ | + | |
| Annual TSH† | + | +§§ | + |
| Dental assessment§, ‡‡ | + | ||
NCCN (National Cancer Centre Network) Guidelines 10 – Provides guidelines for management of head and neck cancer.
AHNS (American Head and Neck Society) quality indicators 13 – First introduction to quality measures in head and neck cancers (oral cavity) in 2009.
Scottish Task Force v1 – First set of quality performance indicators developed and evaluated in 2016 in Scotland.
Nationally benchmarked.
Imaging of primary, neck and chest.
Evaluated against guidelines.
Referral only.
Frequency not stated, regular follow up.
Surveillance for lung metastasis not assessed.
Required only at/before 12 months.